All In Biotech

Drug Trial Radar · NCT06671496

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 601 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

601

Actual

Start

Mar 10, 2025

Primary completion

May 18, 2027

Study completion Jan 26, 2028

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Nov 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.

Conditions

  • Psoriatic Arthritis

Interventions

  • ZasocitinibDrug

    Zasocitinib tablets.

  • PlaceboDrug

    Zasocitinib matching placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving American College of Rheumatology 20 (ACR20) Response at Week 16 for Zasocitinib Dose A and B Compared to PlaceboTime frame: At Week 16

Locations

120 sites in 12 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

    Mesa, Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

    Phoenix, Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

    Tucson, Arizona

  • Biovin Enterprises LLC dba Medvin Clinical Research | Covina, CA

    Covina, California

  • RASF- Clinical Research Center

    Boca Raton, Florida

  • Direct Helpers Medical Center

    Hialeah, Florida

  • IRIS Research and Development | Plantation, FL

    Plantation, Florida

  • BayCare Medical Group

    St. Petersburg, Florida

  • North Georgia Rheumatology Group PC

    Lawrenceville, Georgia

  • Clinic of Robert Hozman

    Skokie, Illinois

  • Graves Gilbert Clinic

    Bowling Green, Kentucky

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Advanced Rheumatology PC | Lansing, MI

    Lansing, Michigan

  • AARR- Kansas City Physician Partners

    Kansas City, Missouri

  • DJL Clinical Research | Charlotte, NC

    Charlotte, North Carolina

  • University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division

    Cleveland, Ohio

  • Paramount Medical Research & Consulting, LLC

    Middleburg Heights, Ohio

  • Altoona Center for Clinical Research | Ducansville, PA

    Duncansville, Pennsylvania

  • AARR- Lone Star Arthritis & Rheumatology Associates

    Fort Worth, Texas

  • Biopharma Informatic | Hassan

    Houston, Texas

  • Advanced Rheumatology of Houston - The Woodlands

    The Woodlands, Texas

  • Swedish Rheumatology Research

    Seattle, Washington

  • APRILLUS Asistencia e Investigacion Clinica

    Buenos Aires, Argentina

  • Consultora Integral de Salud Centro Medico Privado SRL | Cordoba, Argentina

    Córdoba, Argentina

  • CER San Juan, Centro Polivalente de Asistencia e Investigacion Clinica

    San Juan, Argentina

  • Instituto de Investigaciones Clinicas Quilmes

    Quilmes, Buenos Aires, Argentina

  • Clinica Regional del Sud S.A.

    Río Cuarto, Córdoba Province, Argentina

  • Centro de Investigaciones Reumatologicas

    San Miguel de Tucumán, Tucumán Province, Argentina

  • CIMER

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Sunshine Coast University Private Hospital | Clinical Trials

    Sippy Downs, Queensland, Australia

  • The Queen Elizabeth Hospital | Rheumatology Department

    Woodville South, South Australia, Australia

  • Fiona Stanley Hospital

    Palmyra Dc, Western Australia, Australia

  • Colin Bayliss Research and Teaching Unit

    Victoria Park, Western Australia, Australia

  • CEPIC - Centro Paulista de Investigacao Clinica

    São Paulo, Brazil

  • CMIP-Centro Mineiro de Pesquisa Ltda

    Juiz de Fora, Minas Gerais, Brazil

  • Universidade Federal de Uberlandia (UFU) - Campus Santa Monica - Centro de Pesquisa Clinica

    Uberlândia, Minas Gerais, Brazil

  • EDUMED - Educacao em Saude SS Ltda

    Curitiba, Paraná, Brazil

  • LMK Servicos Medicos Sociedade Simples

    Porto Alegre, Rio Grande do Sul, Brazil

Showing 40 of 120 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.